Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13.11. | Gemina Laboratories Ltd.: Gemina Laboratories Announces Private Placement | 179 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / November 13, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7)(OCTQB:GLABF) (the "Company" or "Gemina") is pleased to announce a non-brokered private placement offering... ► Artikel lesen | |
27.07. | Gemina Laboratories Ltd: Gemina receives $435,000 from warrant exercises | 1 | Stockwatch | ||
11.07. | Gemina Laboratories Ltd: Gemina in talks with four diagnostic companies | 1 | Stockwatch | ||
10.07. | Gemina Laboratories Ltd.: Gemina Laboratories Strategic Update | 296 | ACCESSWIRE | ACCELERATING COMMERCIALISATION VANCOUVER, BC / ACCESSWIRE / July 10, 2024 / Gemina Laboratories Ltd (CSE:GLAB)(OTCQB:GLABF)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide a strategic update... ► Artikel lesen | |
21.06. | 'Biggest Invention Since Lateral Flow': Gemina Labs CEO Touts Company's Transformative Diagnostics Deal | 1 | Benzinga.com | ||
20.06. | Gemina Laboratories Ltd: Gemina Laboratories begins trading on OTCQB | 1 | Stockwatch | ||
20.06. | Gemina Laboratories Ltd.: Gemina Laboratories Commences Trading on the OTCQB Market in the United States | 426 | ACCESSWIRE | Gemina Laboratories (OTCQB: GLABF), (CSE: GLAB), (FRA: 817) expands investor reach to U.S. by posting shares on OTCQB. VANCOUVER, BC / ACCESSWIRE / June 20, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(OTCQB:GLABF)(FRA:8I7)... ► Artikel lesen | |
GEMINA LABORATORIES Aktie jetzt für 0€ handeln | |||||
09.04. | Gemina Laboratories Ltd.: Gemina Labs Announces Addition to its IP Portfolio | 191 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE /April 9, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") today announces that it has licensed a novel biosensing architecture from the University... ► Artikel lesen | |
02.04. | Gemina Laboratories Ltd.: Gemina Laboratories Sign First Strategic License Agreement | 297 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / April 2, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce the signing of a license agreement with a significant global... ► Artikel lesen | |
21.03. | Gemina Laboratories Ltd.: Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships | 283 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / March 21, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to provide a strategic update and outlook for 2024 and beyond. The Company... ► Artikel lesen | |
19.03. | Gemina Laboratories Ltd.: Gemina Announces Closing of $910,000 Convertible Note Financing | 277 | ACCESSWIRE | VANCOUVER, BC / ACCESSWIRE / March 19, 2024 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to announce that further to its news release dated February 22, 2024... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PROCEPT BIOROBOTICS | 92,70 | -0,93 % | PROCEPT started with Hold at Jefferies on valuation | ||
FRESENIUS | 32,680 | +1,46 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 44 auf 42 Euro gesenkt, aber die Einstufung auf "Buy" belassen. "Nächster Schritt: Revitalisierung",... ► Artikel lesen | |
ATRICURE | 36,030 | -0,85 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 20,790 | -1,52 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
CARL ZEISS MEDITEC | 54,95 | -3,43 % | Carl Zeiss Meditec Aktie: Am Abgrund? | Die Aktie von Carl Zeiss Meditec erlebte am Freitag einen weiteren Rückschlag an der Börse. Im XETRA-Handel verzeichnete das Papier des Medizintechnikunternehmens deutliche Einbußen und fiel zeitweise... ► Artikel lesen | |
GENEDX | 69,40 | 0,00 % | GeneDx Holdings Corp. (NASDAQ:WGS) Major Shareholder Sells $8,973,629.96 in Stock | ||
TEMPUS AI | 58,12 | +7,69 % | Cathie Wood's ARK ETFs Adjust Portfolio with Notable Tesla and Tempus AI Stock Trades | ||
NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 11,980 | +8,03 % | Alignment Healthcare announces offering of $330M convertible debt | ||
PROGYNY | 13,980 | 0,00 % | Barclays Lowers Progyny (NASDAQ:PGNY) Price Target to $17.00 | ||
GERRESHEIMER | 69,40 | -1,07 % | Aixtron, Gerresheimer, Hugo Boss, K+S, Lufthansa, Rheinmetall u.a. - Aktien-Positionen der Shortseller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,320 | -0,76 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers nach einer Investorenveranstaltung mit einem Kursziel von 65,90 Euro auf "Overweight" belassen. Die Themen... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 41,370 | +1,40 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
ENDRA LIFE SCIENCES | 5,070 | 0,00 % | ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update | ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months... ► Artikel lesen | |
RXSIGHT | 44,830 | 0,00 % | Rxsight Co-Präsident Ilya Goldshleger verkauft Aktien im Wert von 363.752 US-Dollar |